Odyssey Therapeutics | Series DSep 2025$210M | $700M |
| Co-investors: Elena Viboch (General Catalyst), Ravi Mhatre (Lightspeed Venture Partners), Lorence Kim (Third Rock Ventures), Carl Gordon (OrbiMed Advisors), Jill carroll (SR One), Brenton Fargnoli (AlleyCorp), Nan Li (6 Dimensions Capital) |
Neuralink | Series EMay 2025$650M | $1.2B |
| Co-investors: Peter Thiel (Founders Fund), Michael Mignano (Lightspeed Venture Partners), Shaun Maguire (Sequoia Capital), Andrew Reed (Sequoia Capital), Ravi Mhatre (Lightspeed Venture Partners), Fred Ehrsam (Paradigm), Krishna Yeshwant (GV (Google Ventures)), David Krane (GV (Google Ventures)), Brenton Fargnoli (AlleyCorp), Robert Nelsen (ARCH Venture Partners), Bryan Rosenblatt (Craft Ventures), Ken Howery (Unknown Ventures), Blake Byers (NewLimit), Bill Lee (Craft Ventures), Sam Altman, Shane Neman |
Antares Therapeutics | Series AMay 2025$180M | $180M |
| Co-investors: Ravi Mhatre (Lightspeed Venture Partners), Jean-François Formela (Atlas Venture), Brenton Fargnoli (AlleyCorp) |
Frontera Health | SeedFeb 2025$32M | $32M |
| Co-investors: Galym Imanbayev (Lightspeed Venture Partners), Bilal Zuberi (Lux Capital), Alexa von Tobel (Inspired Capital) |
Aledade | Series FJun 2023$260M | $550M |
| Co-investors: Craig Sherman (Meritech Capital Partners), Jules Maltz (IVP), Somesh Dash (IVP), Galym Imanbayev (Lightspeed Venture Partners), Will Kohler (Lightspeed Venture Partners), Bob Kocher (Venrock) |
Zag Bio | SeedJan 2023 | $80M |
| Co-investors: Ravi Mhatre (Lightspeed Venture Partners), Galym Imanbayev (Lightspeed Venture Partners), Alan Crane (Polaris Partners), Johannes Fruehauf (Mission BioCapital) |
Ancora Biotech | Series AJun 2022$60M | $60M |
| Co-investors: Galym Imanbayev (Lightspeed Venture Partners), Chris Schaepe |
Ultima Genomics | Series UnknownMay 2022$600M | $600M |
| Co-investors: Yoni Cheifetz (Lightspeed Venture Partners), Marius Nacht (Cyberstarts VC) |